Investment Firm Novo Names Moelis’s Kutay as New Chief ExecutiveBy
Kutay starts in his new role in September based in Copenhagen
Novo manages more than 350 billion kroner in foundation assets
Novo A/S, the investment fund that holds stakes in health-care companies including Novo Nordisk A/S and Novozymes A/S, has hired Kasim Kutay from financial adviser Moelis & Co. to be its new chief executive officer.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.